期刊文献+

骨桥蛋白在胰腺癌中的表达及其临床意义

Expression of Osteopontin in Pancreatic Cancer and Its Clinical Significance
原文传递
导出
摘要 目的:研究骨桥蛋白OPN在胰腺癌中的表达水平及其与临床病理特征的关系。方法:采用RT-PCR和免疫组织化学方法分别检测50例胰腺癌手术切除标本和20例癌旁正常胰腺组织中OPNmRNA及其蛋白水平的表达。结果:胰腺癌组织中OPNmRNA高表达率为90%(45/50)明显高于其在癌旁正常胰腺组织中的表达15%(3/20),差异有统计学意义(P<0.01);OPN蛋白的阳性率为86.0%(43/50),明显高于癌旁正常胰腺组织中的表达30%(6/20),差异有统计学意义(P<0.01);OPN在胰腺癌组织中表达与其淋巴结转移明显相关(P<0.05)。结论:OPN在胰腺癌中的过表达对胰腺癌的生长、浸润及转移起重要作用。 To study the mRNA and protein expression levels of osteopontin in pancreatic cancer and the relationship with clinic pathological features. Methods: Amount of 50 cases of pancreatic cancer surgical specimens and 20 cases of adjacent normal tissue were studied. The OPN mRNA and protein expression levels were detected by RT-PCR and immunohistochemistry respectively. Results: RT-PCR analysis showed that the OPN mRNA were highly expressed in pancreatic tissues (45/50, 90 % ), which was significantly higher than in adjacent normal tissues (3/20, 15 %) (P〈0.01). Immunohistochemistry analysis demonstrated that the OPN protein was high expressed in pancreatic tissues (43/50, 86 %), which was significantly higher than in adjacent normal tissue (6/20, 30 %) (P〈0.01). The expression levels of OPN in pancreatic cancer were obviously associated with lymph node metastasis (P〈0.05). Conclusion: The OPN was overexpressed in pancreatic cancer, which maybe played important roles in the growth, invasion and metastasis of cancer.
出处 《现代生物医学进展》 CAS 2012年第5期915-917,共3页 Progress in Modern Biomedicine
关键词 胰腺癌 骨桥蛋白 RT-PCR 免疫组织化学 Pancreatic cancer Osteopontin RT-PCR lmmunohistochemistry
  • 引文网络
  • 相关文献

参考文献10

  • 1Wai PY,Kuo PC.The role of Osteopontin in tumor metastasis[J].J Surg Res,2004,121(2):228-241.
  • 2Kilic G,Wang J,Sosa-Pineda B.Osteopontin Is a Novel Marker of Pa-ncreatic Ductal Tissues and of Undifferentiated Pancreatic Precursors in Mice[J].Dev Dyn,2006,235(6):1659-1667.
  • 3Schnelldorfer T,Ware AL,Sarr MG,et al.Long-term survival after pa-ncreatoduodenectomy for pancreatic adenocarcinoma:is cure possible?[J].Ann Surg,2008,247(3):456-462.
  • 4Senger DR,Wirth DF,Hynes RO.Transformed mammalian cells secr-etespecificproteinsand phosphoproteins[J].Cell,1979,16(4):885-893.
  • 5Craig AM,Smith JH,Denhardt DT.Osteopontin,a transformation-ass-ociated cell adhesion phosphoprotein,isinduced by12-O-tetradecano-ylphorbol13-acetate in mouse epidermis[J].J Biol Chem,1989,264(16):9682-9689.
  • 6Rangaswami H,Bulbule A,Kundu GC.Osteopontin:role in cellsigna-ling and cancer progression[J].Trends Cell Biol,2006,16(2):79-87.
  • 7Hotte SJ,Winquist EW,Stitt L,et al.Plasma osteopontin:associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma[J].Cancer,2002,95(3):506-512.
  • 8Gilbert M,Shaw WJ,Long JR,et al.Chimeric peptides of statherin and osteopontin that bind hydroxyapatite and mediate cell adhesion[J].J Biol Chem,2000,275(21):16213-16218.
  • 9Khan S A,Cook A C,Kappil M,et al.Enhanced cell surface CD44va-riant(v6,v9)expression by osteopontin in breast cancer epit helial cel-ls facilitates tumor cell migration:Novel post-t ranscriptional,post-t ranslational regulation[J].Clin Exp Metastasis,2005,22(8):663-673.
  • 10Kolb A,Kleeff J,Guweidhi A,et al.Osteopontin Influences the Inva-siveness of Pancreatic Cancer Cells and is Increased in Neoplastic an-d Inflammatory Conditions[J].Cancer Biol Ther,2005,4(7):740-746.
;
使用帮助 返回顶部